SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 194 filers reported holding SAGE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $3,477,000 | -67.9% | 36,300 | -84.6% | 0.06% | -48.0% |
| Q3 2016 | $10,840,000 | +70.8% | 235,400 | +56.9% | 0.12% | +92.2% |
| Q3 2015 | $6,348,000 | -42.0% | 149,999 | -0.0% | 0.06% | -20.0% |
| Q2 2015 | $10,950,000 | -47.1% | 150,000 | -63.6% | 0.08% | -54.8% |
| Q1 2015 | $20,712,000 | +37.2% | 412,335 | 0.0% | 0.18% | +22.9% |
| Q4 2014 | $15,091,000 | -10.8% | 412,335 | -23.3% | 0.14% | -18.6% |
| Q3 2014 | $16,926,000 | – | 537,335 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 409,000 | $17,399,000 | 4.82% |
| Palo Alto Investors LP | 781,730 | $33,255,000 | 2.12% |
| DAFNA Capital Management LLC | 180,306 | $7,670,000 | 1.93% |
| Boxer Capital, LLC | 1,094,000 | $46,539,000 | 1.81% |
| Deep Track Capital, LP | 500,000 | $21,270,000 | 1.50% |
| Bellevue Group AG | 3,228,004 | $137,319,000 | 1.42% |
| EcoR1 Capital, LLC | 940,636 | $40,015,000 | 1.28% |
| Deep Track Capital, LP | 400,000 | $17,016,000 | 1.20% |
| Artal Group S.A. | 1,000,000 | $42,540,000 | 1.15% |
| SECTOR GAMMA AS | 98,904 | $4,207,000 | 0.99% |